MARKET

MDT

MDT

Medtronic
NYSE

Real-time Quotes | Nasdaq Last Sale

123.63
+1.84
+1.51%
After Hours: 123.98 +0.35 +0.28% 19:59 04/13 EDT
OPEN
121.44
PREV CLOSE
121.79
HIGH
123.91
LOW
121.26
VOLUME
6.24M
TURNOVER
--
52 WEEK HIGH
123.91
52 WEEK LOW
87.68
MARKET CAP
166.66B
P/E (TTM)
58.50
1D
5D
1M
3M
1Y
5Y
Outlook on the End Stage Renal Disease Global Market to 2025 - Competitive Analysis and Impact of COVID-19
, /PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 7h ago
Medtronic PLC stock outperforms market on strong trading day
Shares of Medtronic PLC advanced 1.51% to $123.63 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...
marketwatch.com · 7h ago
Worldwide Artificial Organ and Bionics Industry to 2025 - Advantageous in Comparison Prosthetics Presents Opportunities
, /PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 10h ago
Medtronic's (MDT) GI Genius Module Gets FDA De Novo Clearance
Medtronic's (MDT) GI Genius Module is the only commercially available computer-aided detection system which uses artificial intelligence to identify colorectal polyploid.
Zacks · 15h ago
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12)
Benzinga · 16h ago
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher, T-Mobile, Medtronic and Square
Zacks.com · 17h ago
Hemostasis Products Market to Grow at a CAGR of 4.6% During the Forecast Period 2021-2026
Apr 12, 2021 (AB Digital via COMTEX) -- Hemostasis Products Market size in 2020 is estimated to be $1.52 billion, growing at a CAGR of 4.6% during the...
ABNewswire · 1d ago
Radiofrequency Ablation Devices for Pain Management Market Size Estimated to Reach $1.04 Billion by 2026
Apr 12, 2021 (AB Digital via COMTEX) -- Radiofrequency Ablation Devices for Pain Management Market size is estimated to reach $1.04 billion by 2026, growing...
ABNewswire · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MDT. Analyze the recent business situations of Medtronic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 27 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MDT stock price target is 133.36 with a high estimate of 150.00 and a low estimate of 122.00.
EPS
Institutional Holdings
Institutions: 2.42K
Institutional Holdings: 1.15B
% Owned: 85.03%
Shares Outstanding: 1.35B
TypeInstitutionsShares
Increased
814
40.84M
New
242
5.20M
Decreased
640
43.50M
Sold Out
81
4.17M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.85%
Healthcare Equipment & Supplies
+1.78%
Key Executives
Chairman/President/Chief Executive Officer/Executive Director
Geoffrey Martha
Chief Financial Officer/Executive Vice President
Karen Parkhill
Chief Human Resource Officer/Senior Vice President
Carol Surface
Executive Vice President
Robert ten Hoedt
Executive Vice President
John Liddicoat
Executive Vice President
Sean Salmon
Executive Vice President
Brett Wall
Executive Vice President
Robert White
Senior Vice President/Chief Scientific Officer
Richard Kuntz
Senior Vice President/General Counsel/Secretary
Bradley Lerman
Independent Director
Richard Anderson
Independent Director
Craig Arnold
Independent Director
Scott Donnelly
Independent Director
Andrea Goldsmith
Independent Director
Randall Hogan
Independent Director
Michael Leavitt
Independent Director
James Lenehan
Independent Director
Kevin Lofton
Independent Director
Elizabeth Nabel
Independent Director
Denise O'Leary
Independent Director
Kendall Powell
Declaration Date
Dividend Per Share
Ex-Div Date
03/08/2021
Dividend USD 0.58
03/25/2021
12/11/2020
Dividend USD 0.58
12/21/2020
08/21/2020
Dividend USD 0.58
09/24/2020
05/20/2020
Dividend USD 0.58
06/25/2020
03/06/2020
Dividend USD 0.54
03/26/2020
12/06/2019
Dividend USD 0.54
12/26/2019
08/23/2019
Dividend USD 0.54
09/26/2019
06/21/2019
Dividend USD 0.54
07/05/2019
03/08/2019
Dividend USD 0.5
03/21/2019
12/07/2018
Dividend USD 0.5
12/27/2018
08/24/2018
Dividend USD 0.5
09/27/2018
06/22/2018
Dividend USD 0.5
07/05/2018
03/09/2018
Dividend USD 0.46
03/22/2018
12/08/2017
Dividend USD 0.46
12/28/2017
08/25/2017
Dividend USD 0.46
09/28/2017
06/23/2017
Dividend USD 0.46
07/05/2017
03/10/2017
Dividend USD 0.43
03/22/2017
12/09/2016
Dividend USD 0.43
12/21/2016
08/22/2016
Dividend USD 0.43
09/27/2016
06/24/2016
Dividend USD 0.43
07/06/2016
02/19/2016
Dividend USD 0.38
03/22/2016
12/11/2015
Dividend USD 0.38
12/22/2015
08/21/2015
Dividend USD 0.38
09/23/2015
06/19/2015
Dividend USD 0.38
06/25/2015
02/13/2015
Dividend USD 0.305
03/26/2015
12/04/2014
Dividend USD 0.305
12/30/2014
08/22/2014
Dividend USD 0.305
10/01/2014
06/16/2014
Dividend USD 0.305
07/01/2014
02/14/2014
Dividend USD 0.28
04/02/2014
12/06/2013
Dividend USD 0.28
12/31/2013
08/23/2013
Dividend USD 0.28
10/02/2013
06/21/2013
Dividend USD 0.28
07/02/2013
About MDT
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Webull offers kinds of Medtronic PLC stock information, including NYSE:MDT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MDT stock methods without spending real money on the virtual paper trading platform.